This contract expires in 158 days (Mar 31, 2027).
HEXAMER THERAPEUTICS INC. - RESEARCH AND DEVELOPMENT SERVICES BA230121 TITLED SELF ASSEMBLING VACCINE PLATFORM
Key Details
Description
RESEARCH AND DEVELOPMENT SERVICES BA230121 TITLED SELF ASSEMBLING VACCINE PLATFORM
Context & Analysis
On Nov 25, 2025, Department of Defense obligated $3,928,061.02 to HEXAMER THERAPEUTICS INC. for research and development services ba230121 titled self assembling vaccine platform. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PULLMAN, WA. The contract is scheduled through Mar 31, 2027 — approximately 5 months remaining. This award is one of several similar procurements from Department of Defense under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
GBI/AUR PROGRAM MANAGEMENT/SYSTEMS ENG
THE BOEING COMPANY
$4.4B
NGJ LB CB1 DEVELOPMENT
L3 TECHNOLOGIES, INC.
$179.6M
UNFUNDED LABOR
AVIAN, LLC
$53.8M
REEFENSE PROGRAM SEEKS TO DEVELOP A SOLUTION THAT RAPIDLY PROVIDES PROTECTION FOR US DEPARTMENT OF DEFENSE COASTAL INFRASTRUCTURE.
UNIVERSITY OF HAWAII
$22.3M
REEFENSE PROGRAM PHASE 1 SEEKS TO DEVELOP SELF HEALING, HYBRID BIOLOGICAL, AND ENGINEERED REEF-MIMICKING STRUCTURES TO MITIGATE THE COASTAL FLOODING, EROSION, AND STORM DAMAGE THAT INCREASINGLY THREATEN CIVILIAN AND DOD INFRASTRUCTURE AND PERSONNEL.
RUTGERS, THE STATE UNIVERSITY
$11.3M
Stay Updated
Get notified about new opportunities matching your interests.